Karnataka moves Supreme Court against Snapdeal over sale of erectile dysfunction tablets

The Karnataka government has moved the Supreme Court against Snapdeal over the sale of erectile dysfunction tablets through its platform without a licence or prescription. The court has sought Snapdeal's response to the plea, which challenges a Karnataka High Court judgment that set aside criminal proceedings against Snapdeal and its directors. The case arose from an online order placed for Suhagra-100 Tablets, a prescription medicine sold by third-party seller M/s Herbal Healthcare without a valid licence or doctor's prescription.

The Supreme Court has been drawn into a dispute between the Karnataka government and e-commerce platform Snapdeal over the sale of prescription drugs through its online platform. The court's intervention follows a recent judgment from the Karnataka High Court, which set aside criminal proceedings against Snapdeal and its directors. This development highlights the complexities surrounding online sales of prescription medications in India.

The case at hand involves the sale of Suhagra Tablets, a prescription medicine used to treat erectile dysfunction in men. The prosecution alleged that third-party seller M/s Herbal Healthcare sold the drug without a valid licence or doctor's prescription, violating the Drugs and Cosmetics Rules, 1945. This raises questions about the regulatory framework governing online sales of prescription medications in India.

The Supreme Court's decision to seek Snapdeal's response to the plea filed by the Karnataka government underscores the importance of ensuring compliance with regulatory requirements for online sales of prescription drugs. The case highlights the need for clarity on the responsibilities of e-commerce platforms and third-party sellers in ensuring that prescription medications are sold lawfully. Furthermore, this development raises questions about the effectiveness of existing regulations in preventing the sale of prescription medications without a licence or doctor's prescription.

The Supreme Court's intervention in this matter is likely to have significant implications for e-commerce platforms and third-party sellers operating in India. Practitioners should be aware of the regulatory requirements governing online sales of prescription medications and ensure that their clients comply with these regulations to avoid potential liability.